Augusto A Miravalle
Title | Affiliate |
---|
Institution | University of Colorado Denver - Anschutz Medical Campus |
---|
Department | SOM-NEUR General Operations |
---|
Phone | 303/724-2187 |
---|
|
|
|
Bibliographic
-
Alvarez E, Nair KV, Hoyt BD, Seale RA, Sillau S, Miravalle A, Engebretson E, Schurr B, Corboy JR, Vollmer TL, Honce JM. Brain atrophy rates in patients with multiple sclerosis on long term natalizumab resembles healthy controls. Mult Scler Relat Disord. 2021 Oct; 55:103170. PMID: 34364034.
-
Swanson CW, Proessl F, Stephens JA, Miravalle AA, Fling BW. Non-invasive brain stimulation to assess neurophysiologic underpinnings of lower limb motor impairment in multiple sclerosis. J Neurosci Methods. 2021 05 15; 356:109143. PMID: 33757762.
-
Miravalle AA, Katz J, Robertson D, Hayward B, Harlow DE, Lebson LA, Sloane JA, Bass AD, Fox EJ. CLICK-MS and MASTER-2 Phase IV?trial design: cladribine tablets in suboptimally controlled relapsing multiple sclerosis. Neurodegener Dis Manag. 2021 04; 11(2):99-111. PMID: 33517769.
-
Rempe T, Carlson A, Miravalle A, Gyang TV. Anti-JCV antibody index does not change during ocrelizumab-treatment. Mult Scler J Exp Transl Clin. 2020 Jul-Sep; 6(3):2055217320960510. PMID: 33029356.
-
Rempe T, Wang Q, Wu Q, Ballur Narayana Reddy V, Newcomer Z, Miravalle A, Mao-Draayer Y. Progressive multifocal leukoencephalopathy and granule cell neuronopathy with novel mutation flanking VP1 C-terminus in natalizumab-extended interval dosing. Neurol Neuroimmunol Neuroinflamm. 2020 05 04; 7(3). PMID: 32198230.
-
Prosperini L, Kinkel RP, Miravalle AA, Iaffaldano P, Fantaccini S. Post-natalizumab disease reactivation in multiple sclerosis: systematic review and meta-analysis. Ther Adv Neurol Disord. 2019; 12:1756286419837809. PMID: 30956686.
-
Honce JM, Nair KV, Sillau S, Valdez B, Miravalle A, Alvarez E, Schreiner T, Corboy JR, Vollmer TL. Rituximab vs placebo induction prior to glatiramer acetate monotherapy in multiple sclerosis. Neurology. 2019 02 12; 92(7):e723-e732. PMID: 30635477.
-
Fox RJ, Coffey CS, Cudkowicz ME, Gleason T, Goodman A, Klawiter EC, Matsuda K, McGovern M, Conwit R, Naismith R, Ashokkumar A, Bermel R, Ecklund D, Koepp M, Long J, Natarajan S, Ramachandran S, Skaramagas T, Thornell B, Yankey J, Agius M, Bashir K, Cohen B, Coyle P, Delgado S, Dewitt D, Flores A, Giesser B, Goldman M, Jubelt B, Lava N, Lynch S, Miravalle A, Moses H, Ontaneda D, Perumal J, Racke M, Repovic P, Riley C, Severson C, Shinnar S, Suski V, Weinstock-Gutman B, Yadav V, Zabeti A. Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis. Contemp Clin Trials. 2016 09; 50:166-77. PMID: 27521810.
-
Korb PJ, Miravalle A. Coding in Multiple Sclerosis and Other Demyelinating Diseases. Continuum (Minneap Minn). 2016 06; 22(3):951-9. PMID: 27261692.
-
Harlow DE, Honce JM, Miravalle AA. Remyelination Therapy in Multiple Sclerosis. Front Neurol. 2015; 6:257. PMID: 26696956.
-
Liewluck T, Miravalle A. Immune-Mediated Neurological Disorders. Curr Neurol Neurosci Rep. 2015 Sep; 15(9):61. PMID: 26202897.
-
Miravalle AA, Schreiner T. Neurologic complications of vaccinations. Handb Clin Neurol. 2014; 121:1549-57. PMID: 24365435.
-
Campbell JD, Ghushchyan V, Brett McQueen R, Cahoon-Metzger S, Livingston T, Vollmer T, Corboy J, Miravalle A, Schreiner T, Porter V, Nair K. Burden of multiple sclerosis on direct, indirect costs and quality of life: National US estimates. Mult Scler Relat Disord. 2014 Mar; 3(2):227-36. PMID: 25878010.
-
Kleinschmidt-DeMasters BK, Miravalle A, Schowinsky J, Corboy J, Vollmer T. Update on PML and PML-IRIS occurring in multiple sclerosis patients treated with natalizumab. J Neuropathol Exp Neurol. 2012 Jul; 71(7):604-17. PMID: 22710964.
-
Schreiner TL, Miravalle A. Current and emerging therapies for the treatment of multiple sclerosis: focus on cladribine. J Cent Nerv Syst Dis. 2012; 4:1-14. PMID: 23650463.
-
Nielsen AS, Miravalle A, Langer-Gould A, Cooper J, Edwards KR, Kinkel RP. Maximally tolerated versus minimally effective dose: the case of rituximab in multiple sclerosis. Mult Scler. 2012 Mar; 18(3):377-8. PMID: 21828201.
-
Miravalle AA. Guidelines and best practices for appropriate use of dalfampridine in managed care populations. Am J Manag Care. 2011 May; 17 Suppl 5 Improving:S154-60. PMID: 21761954.
-
Kala M, Miravalle A, Vollmer T. Recent insights into the mechanism of action of glatiramer acetate. J Neuroimmunol. 2011 Jun; 235(1-2):9-17. PMID: 21402415.
-
Miravalle A, Corboy JR. Therapeutic options in multiple sclerosis: five new things. Neurology. 2010 Nov 02; 75(18 Suppl 1):S22-7. PMID: 21041767.
-
Bennett JL, Miravalle AA. Recent advances in the treatment of multiple sclerosis. J Exp Pharmacol. 2010; 2:155-61. PMID: 27186101.
-
Miravalle A, Jensen R, Kinkel RP. Immune reconstitution inflammatory syndrome in patients with multiple sclerosis following cessation of natalizumab therapy. Arch Neurol. 2011 Feb; 68(2):186-91. PMID: 20937940.
-
Berger JR, Centonze D, Comi G, Confavreux C, Cutter G, Giovannoni G, Gold R, Hartung HP, Lublin F, Miravalle A, Montalban X, O'Connor P, Olsson T, Polman CH, Stuve O, Wolinsky JS, Ziemssen T. Considerations on discontinuing natalizumab for the treatment of multiple sclerosis. Ann Neurol. 2010 Sep; 68(3):409-11. PMID: 20818795.
-
Corboy JR, Miravalle AA. Emerging therapies for treatment of multiple sclerosis. J Inflamm Res. 2010; 3:53-9. PMID: 22096357.
-
Miravalle A, Biller J, Schnitzler E, Bonwit A. Neurological complications following vaccinations. Neurol Res. 2010 Apr; 32(3):285-92. PMID: 20406607.
-
Miravalle A, Biller J, Silva E, Conneely M, O'Keefe P. Acute disseminated encephalomyelitis: yellow fever vaccination. Arq Neuropsiquiatr. 2009 Sep; 67(3A):710-1. PMID: 19722058.
-
Miravalle A, Roos KL. Encephalitis complicating smallpox vaccination. Arch Neurol. 2003 Jul; 60(7):925-8. PMID: 12873847.
This graph shows the total number of publications by year, by first, middle/unknown, or last author.
To see the data from this visualization as text, click here.
Year | Publications |
---|
2003 | 1 | 2009 | 1 | 2010 | 6 | 2011 | 3 | 2012 | 2 | 2013 | 1 | 2014 | 1 | 2015 | 2 | 2016 | 2 | 2019 | 2 | 2020 | 2 | 2021 | 3 |
To return to the timeline, click here.
|
Miravalle's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|